This is a Validated Antibody Database (VAD) review about rat Tusc3, based on 3 published articles (read how Labome selects the articles), using Tusc3 antibody in all methods. It is aimed to help Labome visitors find the most suited Tusc3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Tusc3 synonym: tumor suppressor candidate 3

Proteintech Group
rabbit polyclonal
  • western blot; human; fig 1,2,3,4,5,6
In order to determine how N-glycosylation of cysteine-proximal acceptor sites in glycoproteins requires oxidoreductase activity, Proteintech Group Tusc3 antibody (Proteintech Group, 16039) was used in western blot on human samples (fig 1,2,3,4,5,6). J Cell Biol (2014) ncbi
Sigma-Aldrich
rabbit polyclonal
  • immunocytochemistry; human; 1:500; loading ...; fig 1h
  • immunohistochemistry; human; 1:500; loading ...; fig 1a
Sigma-Aldrich Tusc3 antibody (Cell Signaling, SAB4503183) was used in immunocytochemistry on human samples at 1:500 (fig 1h) and in immunohistochemistry on human samples at 1:500 (fig 1a). Nat Commun (2018) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3a
In order to characterize the cell biology associated with Dengue virus infection, Sigma-Aldrich Tusc3 antibody (Sigma, SAB4503183) was used in western blot on human samples at 1:1000 (fig 3a). MBio (2017) ncbi
Articles Reviewed
  1. Jeon Y, Kim T, Park D, Nuovo G, Rhee S, Joshi P, et al. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC. Nat Commun. 2018;9:5110 pubmed publisher
  2. Lin D, Cherepanova N, Bozzacco L, Macdonald M, Gilmore R, Tai A. Dengue Virus Hijacks a Noncanonical Oxidoreductase Function of a Cellular Oligosaccharyltransferase Complex. MBio. 2017;8: pubmed publisher
  3. Cherepanova N, Shrimal S, Gilmore R. Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins. J Cell Biol. 2014;206:525-39 pubmed publisher